Bentham Science Logo
Journal Cover

Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Continued as: Endocrine, Metabolic & Immune Disorders - Drug Targets

ISSN: 1875-5917 (Online)
ISSN: 1568-0088 (Print)
This journal supports open access

Aims & Scope

This journal is devoted to full-length/ mini reviews and original articles of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Moreover, the topics related to the effects of food components and/or nutraceuticals on the endocrine-metabolic-immune axis and on microbioma composition are welcome.

Current Drug Targets - Immune, Endocrine & Metabolic Disorders

,

Volume 5

-

Number 4






Molecular Basis of Therapeutic Strategies for Breast Cancer

, 5(4): 379 - 396

Jing Huang, Xiaodong Li, Russell Hilf, Robert A. Bambara and Mesut Muyan


DOI: 10.2174/1568005310505040379



Failure of Immune Homeostasis - The Consequences of Under and Over Reactivity

, 5(4): 413 - 423

B. Crimeen-Irwin, K. Scalzo, S. Gloster, P. L. Mottram and M. Plebanski


DOI: 10.2174/1568005310505040413




Articles Ahead of Print

There are currently no Articles Ahead of Print available for this journal.

Abstracts Ahead of Print

There are currently no Abstracts Ahead of Print available for this journal.

Editor's Choice

Open Access Articles


About the Journal

For Librarians & Readers

Related Journals

Related eBooks

eBooks Catalog